Navigation Links
Techne Corporation Announces Acquisition Agreement
Date:6/18/2013

MINNEAPOLIS, June 18, 2013 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) (Techne) announced today that it has agreed to acquire 100% ownership of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics).  Bionostics is a global leader in the development, manufacture and distribution of control solutions that verify the proper operation of in vitro diagnostic (IVD) devices primarily utilized in point of care blood glucose and blood gas testing.  Biosnostics has strategic supply relationships with virtually all global IVD device Original Equipment Manufacturers (OEMs).  The transaction is expected to close in the first quarter of fiscal 2014, subject to the satisfaction of customary closing conditions, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.  The acquisition is not subject to any financing contingencies.

Techne, through its subsidiaries R&D Systems and R&D Systems Europe, is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls.  Bionostics and Techne's Hematology Division will collectively operate under a new Clinical Controls Division of R&D Systems after close of the transaction.

Bionostics was founded in 1981 and is based in Devens, Massachusetts.  Its controls are proprietary device-specific formulations which require FDA 510(k) approval.  Like the products made by R&D Systems' Hematology Division, each control is also a component of the OEM's 510(k), making Bionostics' controls integral to each diagnostic device.  Controls for blood glucose and blood gas devices are the largest portion of Bionostics' business.  Bionostics recently launched coagulation device
'/>"/>

SOURCE Techne Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Techne Corporation Releases Unaudited Third Quarter And Nine Month Fiscal Year 2013 Results
2. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
3. Techne Corporation Declares Dividend And Announces An Increase In Its Share Repurchase Program
4. Techne Corporation Declares Dividend
5. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
6. Celsion Corporation Announces $9.83 Million Registered Direct Offering
7. Sigma-Aldrich Corporation Presentations At Three Upcoming Conferences To Be Webcast Live
8. Celladon Corporation Selected as Winner of Red Herrings "Top 100 North America Tech Startup"
9. The Renewable Corporation (RNWB) through its wholly owned subsidiary EcoSmart Surface & Coating Technologies receives results from Product Test Service.
10. Cadwalader Advises Elan Corporation in Billion Dollar Royalty Deal
11. Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... DUBLIN , Mar. 04, 2015 Research ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report ... a characteristic that can be objectively measured and ... pathogenic processes as well as pharmacological responses to ...
(Date:3/4/2015)... 4, 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) (the ... a collaborative research program with Emerald Logic, ... Collective Evolution Technology (FACET), Emerald Logic analyzed ... obtained from each of 798 patients who ... trials ASSERT, SUSTAIN and ASSURE. The objective ...
(Date:3/4/2015)... 04, 2015 Proove Biosciences ... Medicine, is excited to announce the launch of ... Optimize the Management of Pain”. , The continuing ... for the next year. The focus of the ... recognize inadequate pain treatments, integrate appropriate pain management ...
(Date:3/4/2015)... Pa. , March 4, 2015 /PRNewswire/ ... services and technology provider, today announced that ... 10 countries convened at its annual European ... to discuss the use of ... challenges. BioClinica,s eClinical technologies include: the Microsoft ...
Breaking Biology Technology:Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3
... (NYSE: DGX ), the nation,s leading provider ... is scheduled to speak,at the Lehman Brothers Eleventh ... at The Loews Miami Beach Hotel, Miami, Florida.,The ... 9:00 a.m.,Eastern Time., The presentation will be ...
... DIEGO, March 14 NuVasive, Inc. (Nasdaq:,NUVA), a medical ... treatments for the spine, announced today,that Kevin O,Boyle, Executive ... at the Lehman Brothers Eleventh Annual Global,Healthcare Conference at ... on,Wednesday, March 19, 2008 at 10:15 a.m. ET., ...
... webcast live and archived on Company,s web site, ... (Nasdaq: MBRK ), a pharmaceutical company focused ... Dr. Edward M. Rudnic, MiddleBrook president and CEO, ... 2008, at 4:45 p.m.,Eastern Time., The presentation ...
Cached Biology Technology:Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference 2
(Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ... in general the State of Washington,s ... a new enrollment and central issuance system for driver,s licenses ... The project planning and development will start in January ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) ... U.S Department of Homeland Security (DHS) in conjunction ... determine how airborne contaminants would spread if released ... is now underway and runs from December 5-11, ...
... Though they remain a leading killer, heart attacks ... diagnosed following initial onset of symptoms. In a study ... , researchers have identified cardiac myosin-binding protein C (cMyBP-C) ... one that may be particularly valuable for mild attacks ...
... Kingdom, December, 2009 Newly published research, by investigators, ... in the journal Stem Cells reported the ... Cell Deficiency" (LSCD) using the patients, own stem cells ... LSCD is a painful, blinding disease that ...
Cached Biology News:Berkeley Lab researchers participate in Homeland Security study of subway airflow 2Potential new heart attack biomarker uncovered 2Successful stem cell therapy for treatment of eye disease 2
... 0-10 psi precision pressure regulator and pressurized ... Faster liquid-switching Steady flow rate ... delivery Can be added to any ... Scientific, any third-party manufacturer, even homemade. Connect to ...
...
Chicken polyclonal to UCK2 ( Abpromise for all tested applications). Antigen: Full length protein, corresponding to amino acids 1-261 of Human UCK2 Entrez Gene ID: 7371 Swiss Protein ID: ...
... (rEK) is a highly purified preparation of ... serine protease which recognizes the identical cleavage ... has similar enzymatic activity. Novagen&'s enzyme is ... purified to yield the highest activity available, ...
Biology Products: